[HTML][HTML] Development of targeted therapies in treatment of glioblastoma

YY Xu, P Gao, Y Sun, YR Duan - Cancer biology & medicine, 2015 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is a type of tumor that is highly lethal despite maximal therapy.
Standard therapeutic approaches provide modest improvement in progression-free and …

Cationic and amphipathic cell-penetrating peptides (CPPs): Their structures and in vivo studies in drug delivery

JL Zaro, WC Shen - Frontiers of Chemical Science and Engineering, 2015 - Springer
Over the past few decades, cell penetrating peptides (CPPs) have become an important
class of drug carriers for small molecules, proteins, genes and nanoparticle systems. CPPs …

Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue

JK Saucier-Sawyer, Y Deng, YE Seo… - Journal of drug …, 2015 - Taylor & Francis
Delivery of therapeutic agents to the central nervous system is a significant challenge,
hindering progress in the treatment of diseases such as glioblastoma. Due to the presence …

CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery

J Zhao, B Zhang, S Shen, J Chen, Q Zhang… - Journal of colloid and …, 2015 - Elsevier
Glioblastoma multiforme (GBM) is the most aggressive central nervous system (CNS) tumor
because of its fast development, poor prognosis, difficult control and terrible mortality. Poor …

Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood–brain barrier and glioma cells

J Bruun, TB Larsen, RI Jølck, R Eliasen… - International journal …, 2015 - Taylor & Francis
Clinical applications of siRNA for treating disorders in the central nervous system require
development of systemic stable, safe, and effective delivery vehicles that are able to cross …

Lipid Bilayer Crossing The Gate of Symmetry. Water-Soluble Phenylproline-Based Blood-Brain Barrier Shuttles

P Arranz-Gibert, B Guixer… - Journal of the …, 2015 - ACS Publications
Drug delivery to the brain can be achieved by various means, including blood-brain barrier
(BBB) disruption, neurosurgical-based approaches, and molecular design. Recently …

[HTML][HTML] Paeoniflorin inhibits proliferation and induces apoptosis of human glioma cells via microRNA-16 upregulation and matrix metalloproteinase-9 downregulation

W Li, Z Qi, Z Wei, S Liu, P Wang… - Molecular …, 2015 - spandidos-publications.com
Paeoniflorin is one of the active ingredients of the commonly used herbal medicine derived
from Paeonia, which exhibits anticancer properties. MicroRNA‑16 (miR‑16) is upregulated in …

Taming cell penetrating peptides: never too old to teach old dogs new tricks

Q Zhang, H Gao, Q He - Molecular pharmaceutics, 2015 - ACS Publications
Cell penetrating peptides (CPPs) have received substantial attention due to their intrinsic
property to cross plasma membranes or even as helpers to facilitate the cellular entry of drug …

Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers

J Chen, J Ding, C Xiao, X Zhuang, X Chen - Biomaterials science, 2015 - pubs.rsc.org
Recently, polymeric nanocarriers with shielding surfaces, eg, poly (ethylene glycol) and
small molecules, have been widely applied in antitumor drug delivery mainly because of …

Nanomedicines and stroke: Toward translational research

A Gaudin, K Andrieux, P Couvreur - Journal of Drug Delivery Science and …, 2015 - Elsevier
Since their introduction in the late 60′, nanotechnologies applied to medicine, called
nanomedicines, are believed to have the potential to be the mankind's first “giant step” …